Therapeutic Asset Ratings

186 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
carbidopa Parkinson's Disease	Tanta University	P4	BBB (75)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Postoperative Pain	Tanta University	P4	BBB (74)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Acute Pain	Tanta University	P4	BBB (73)
Sertraline Depression	Tanta University	P4	BBB (73)
PROPRANOLOL Traumatic Brain Injury	Tanta University	P4	BBB (72)
Eloxatin Neuropathy	Tanta University	P3	BBB (72)
Inno-206 Stage IV Breast Cancer	Tanta University	P3	BBB (72)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Electroconvulsive Therapy	Tanta University	P4	BB (71)
Entecavir Liver Fibrosis	Tanta University	P4	BB (70)
LIDOCAINE Opioid Use	Tanta University	P4	BB (70)
10-(1-methylpiperidin-4-ylidene)-5,10-dihydro-4H-benzo[5,6]cyclohepta[1,2-b]thiophen-4-one Hepatic Disease	Tanta University	P4	BB (69)
PHYTONADIONE, (E)-(±)- Variceal Bleeding	Tanta University	P4	BB (69)
ARG Sickle Cell Disease	Tanta University	P3	BB (69)
Pentoxifylline Neuralgia Peripheral	Tanta University	P2/3	BB (69)
Bxcl501 Obesity	Tanta University	P4	BB (68)
Bxcl501 Postoperative Pain	Tanta University	P4	BB (68)
LIDOCAINE Ketamine	Tanta University	P4	BB (68)
LIDOCAINE Levobupivacaine	Tanta University	P4	BB (68)
LIDOCAINE Paravertebral Block	Tanta University	P4	BB (68)
VITAMIN D Vitamin D on Tumor Response and Inflammatory Markers	Tanta University	P4	BB (68)
VITAMIN D Breast Cancer Patients Diagnosed	Tanta University	P2	BB (68)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Levobupivacaine	Tanta University	P4	BB (67)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Paravertebral Block	Tanta University	P4	BB (67)
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- Obesity, Morbid	Tanta University	P4	BB (67)
L-Bupivacaine Acute Pain	Tanta University	P4	BB (67)

Showing 1 to 25 of 186 assets

PreviousPage 1 of 8Next